• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presidio Investors Welcomes Javier Saade as New Operating Partner

    9/6/23 8:00:00 AM ET
    $ABT
    $BAH
    $DOCU
    $PRCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Professional Services
    Consumer Discretionary
    Get the next $ABT alert in real time by email

    Presidio Investors, a leading middle market private equity firm that capitalizes technology, media, and financial services businesses, is pleased to announce that Javier Saade has joined the firm as Operating Partner. Along with Mark Goldman and Scott Bolick, Javier's unique perspective and expertise will further enhance the firm's strategic investment capabilities and create value across the portfolio. He is a principled leader that has over three decades of broad experience as an investor, board member, founder, operating executive, and former policymaker.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230906464989/en/

    Javier Saade (Photo: Business Wire)

    Javier Saade (Photo: Business Wire)

    Karl Schade, Managing Partner, said, "We are thrilled to welcome Javier to our team as our newest operating partner. With an exceptional background in strategy, policy, and operations, he brings a wealth of expertise that will undoubtedly elevate our firm's capabilities. We are excited to collaborate with Javier as we continue to navigate the dynamic landscape of our industry, driving innovation and delivering unparalleled value to our clients."

    Javier recently served as Audit Committee Chair of the Board of SoftBank Vision Fund Investment Corp. (NASDAQ:SVFA), Lead Independent Director of Porch Group, Inc. (NASDAQ:PRCH), Member of the Boards of Advisors of DocuSign, Inc. (NASDAQ:DOCU) and Univision Communications, and Member of the Boards of Trustees of The Nature Conservancy and Pan American Development Foundation. Earlier in his career, he held leadership, operational and investing roles at McKinsey & Company, Booz Allen & Hamilton (NYSE:BAH), Bridgewater Associates (a hedge fund with $160 billion in assets), Paradigm Ventures, Abbott Laboratories (NYSE:ABT), and Air America, a media company he co-founded. He also held a position of public trust as Associate Administrator, Chief of Investment and Innovation of the U.S. Small Business Administration (SBA) leading programs that have invested $120 billion in over 300,000 high growth companies and cutting-edge technologies. In addition, Javier concurrently served on the Committee for Small & Emerging Companies of the U.S. Securities & Exchange Commission (SEC), subsequently served on the Presidential Transition at the Department of Treasury, and currently serves on the Advisory Committee on Trade Policy & Negotiations at the White House.

    "I've known the Managing Partners of Presidio for decades and joining forces with them made all the sense in the world. The entire team's focus on enhancing company operations, driving growth, and creating value is notable and I look forward to helping the firm and its portfolio companies reach their potential," said Javier about joining Presidio.

    Currently he is Chairman of the Board of GP Funding, Inc., a Presidio portfolio company and leading specialty finance company focused on the legal and healthcare sectors. He is also Managing Partner of Impact Master Holdings, Venture Partner at Fenway Summer, Contributor at CNBC, and Executive Fellow at Harvard Business School.

    About Presidio Investors

    Presidio Investors is a leading Austin, Texas-based private equity firm investing in quality businesses in the lower middle market. With a proven history of successful investments, the firm partners with exceptional management teams to create long-term value and achieve superior financial results. Presidio Investors is committed to identifying and capitalizing on compelling investment opportunities that offer significant growth potential. For more information, please visit www.presidioinvestors.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230906464989/en/

    Get the next $ABT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABT
    $BAH
    $DOCU
    $PRCH

    CompanyDatePrice TargetRatingAnalyst
    Booz Allen Hamilton Holding Corporation
    $BAH
    12/12/2025$93.00Neutral
    Citigroup
    Booz Allen Hamilton Holding Corporation
    $BAH
    10/24/2025$90.00Buy → Underperform
    BofA Securities
    Booz Allen Hamilton Holding Corporation
    $BAH
    10/17/2025$105.00Buy → Hold
    TD Cowen
    Abbott Laboratories
    $ABT
    10/10/2025$145.00Buy
    The Benchmark Company
    Porch Group Inc.
    $PRCH
    9/2/2025$21.00Buy
    Goldman
    Booz Allen Hamilton Holding Corporation
    $BAH
    7/22/2025Mkt Perform → Outperform
    William Blair
    Abbott Laboratories
    $ABT
    7/18/2025$145.00Hold → Buy
    Jefferies
    Porch Group Inc.
    $PRCH
    7/1/2025$15.00Buy
    B. Riley Securities
    More analyst ratings

    $ABT
    $BAH
    $DOCU
    $PRCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs

    ISSUED ON BEHALF OF VENTRIPOINT DIAGNOSTICS LTD. VANCOUVER, BC, Dec. 12, 2025 /PRNewswire/ -- USANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, driven by AI systems that deliver laboratory-grade results at the bedside[1]. Meanwhile, healthcare organizations implementing domain-specific AI tools surged 7x in 2025 as financial pressure mounts, with hospital expenses rising 6% annually while revenue grows just 3%[2]. Five publicly traded companies are positioned at the center of this shift, each holding FDA clearance for AI systems that eliminate diagnostic delays and transform patient management

    12/12/25 9:49:00 AM ET
    $ABT
    $CBLL
    $HTFL
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Medical/Dental Instruments

    Abbott's Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

    Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are associated with better metabolic health and lower long-term risk of chronic conditionsNew data from Lingo users highlight how protein supplementation is linked to lower glucose in people who use continuous glucose monitors, especially for people with obesity, a group at higher risk for prediabetes, type 2 diabetes and other chronic conditionsABBOTT PARK, Ill., Dec. 8, 2025 /PRNewswire/ -- Abbott (NYSE:ABT) today announced that Lingo, an over-the-counter continuous glucose monitor (CGM) and app, is now available for Android

    12/8/25 9:00:00 AM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    University of Wisconsin Wins Abbott and Big Ten's 'We Give Blood' Competition as Campaign Donations Surge 319%, Helping Save Nearly 250,000 Lives

    University of Wisconsin wins Abbott and the Big Ten Conference's "We Give Blood" drive, awards $1 million from Abbott to advance student or community healthSecond year of nationwide blood drive saw a 319% increase in overall participation with 83,043 donations and a 168% jump in student donors compared to 2024Big Ten students, alumni, and fans helped save up to 250,000 lives during the college football seasonA recent 'We Give Blood' survey found 92% of participants are very likely to donate again, a promising sign for building a sustainable blood supply for years to comeABBOTT PARK, Ill. and INDIANAPOLIS, Dec. 6, 2025 /PRNewswire/ -- Amid the nation's worst blood shortage in a generation, th

    12/6/25 8:45:00 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    SEC Filings

    View All

    Abbott Laboratories filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

    8-K - ABBOTT LABORATORIES (0000001800) (Filer)

    12/12/25 4:10:48 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-Q filed by DocuSign Inc.

    10-Q - DOCUSIGN, INC. (0001261333) (Filer)

    12/5/25 4:57:27 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by Porch Group Inc.

    SCHEDULE 13G/A - Porch Group, Inc. (0001784535) (Subject)

    12/5/25 9:35:42 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Rozanski Horacio bought $2,014,908 worth of shares (23,800 units at $84.66), increasing direct ownership by 4% to 687,745 units (SEC Form 4)

    4 - Booz Allen Hamilton Holding Corp (0001443646) (Issuer)

    10/30/25 8:39:06 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    Director Amble Joan Lordi bought $121,737 worth of shares (930 units at $130.90), increasing direct ownership by 2% to 56,860 units (SEC Form 4)

    4 - Booz Allen Hamilton Holding Corp (0001443646) (Issuer)

    2/7/25 4:43:51 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    Director Amble Joan Lordi bought $100,505 worth of shares (690 units at $145.66), increasing direct ownership by 1% to 55,930 units (SEC Form 4)

    4 - Booz Allen Hamilton Holding Corp (0001443646) (Issuer)

    12/10/24 4:07:56 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    $ABT
    $BAH
    $DOCU
    $PRCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP AND GROUP PRESIDENT Salvadori Daniel Gesua Sive gifted 1,536 units of Common shares without par value, decreasing direct ownership by 1% to 132,233 units (SEC Form 4)

    4 - ABBOTT LABORATORIES (0000001800) (Issuer)

    12/12/25 5:04:36 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President General Mgr, Growth Chatwani Robert sold $67,453 worth of shares (983 units at $68.62), decreasing direct ownership by 1% to 70,179 units (SEC Form 4)

    4 - DOCUSIGN, INC. (0001261333) (Issuer)

    12/12/25 4:44:02 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    CHIEF FINANCIAL OFFICER Tabak Shawn sold $211,496 worth of shares (22,216 units at $9.52), decreasing direct ownership by 13% to 153,130 units (SEC Form 4)

    4 - Porch Group, Inc. (0001784535) (Issuer)

    12/5/25 5:52:41 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on Booz Allen Hamilton with a new price target

    Citigroup resumed coverage of Booz Allen Hamilton with a rating of Neutral and set a new price target of $93.00

    12/12/25 8:49:14 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    Booz Allen Hamilton downgraded by BofA Securities with a new price target

    BofA Securities downgraded Booz Allen Hamilton from Buy to Underperform and set a new price target of $90.00

    10/24/25 1:05:58 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    Booz Allen Hamilton downgraded by TD Cowen with a new price target

    TD Cowen downgraded Booz Allen Hamilton from Buy to Hold and set a new price target of $105.00

    10/17/25 8:24:56 AM ET
    $BAH
    Professional Services
    Consumer Discretionary

    $ABT
    $BAH
    $DOCU
    $PRCH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 24, 2023 - FDA Approves New Therapy for Rare Form of Blood Cancers Called Myelodysplastic Syndromes

    For Immediate Release: October 24, 2023 Today, the U.S. Food and Drug Administration approved Tibsovo (ivosidenib) for the treatment of adult patients with relapsed or refractory (R/R) myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation as detected by an FDA-approved test. This is the first targeted therapy approved for this indication. The agency also approved the Abbott RealTime

    10/24/23 3:52:17 PM ET
    $ABT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABT
    $BAH
    $DOCU
    $PRCH
    Leadership Updates

    Live Leadership Updates

    View All

    CRH, Carvana and Comfort Systems USA Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

    NEW YORK, Dec. 5, 2025 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, December 22, to coincide with the quarterly rebalance. The changes ensure that each index is more representative of its market capitalization range. The companies being removed from the S&P SmallCap 600 are no longer representative of the small-cap market space.  Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name Action Company Name Ticker GICS Sector Dec 22, 2025  S&P 500 Addition CRH CRH Mat

    12/5/25 5:49:00 PM ET
    $ASIX
    $BAH
    $BWA
    Major Chemicals
    Industrials
    Professional Services
    Consumer Discretionary

    Pipedrive Appoints Regi Vengalil as CFO to Drive Next Stage of AI-Native Growth

    Pipedrive, the easy and effective sales CRM for small companies, today announced the appointment of Regi Vengalil as the company's new Chief Financial Officer. Vengalil brings nearly two decades of financial and strategic leadership experience from high-growth SaaS, fintech, and AI-driven companies, guiding companies through complex market landscapes and driving clarity and discipline in financial operations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202982724/en/Pipedrive appoints Regi Vengalil as CFO to drive next stage of AI-native growth Vengalil joins Pipedrive from Trax Retail, a leader in AI image recognition softw

    12/2/25 7:00:00 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    SHARON AI To Appoint Mr Drew Kelton To Board of Directors

    SHARON AI, Inc. ("SHARON AI"), Australia's leading Neocloud, is pleased to announce that highly experienced global technology executive Mr Drew Kelton has agreed to join the Sharon AI Holdings Inc board of directors. Mr Kelton is a global business leader and professional board director. With 40 years' experience in the information and communications technology arena, he has held senior roles in the UK, Europe, India, Australasia and the US. "SHARON AI is building the next generation of sovereign AI and digital infrastructure, and I'm excited to be part of a company with both the vision and capability to lead this transformation," said Drew Kelton. Mr Kelton was previously Chief Executive

    12/1/25 3:06:00 PM ET
    $DOCU
    $TMUS
    Computer Software: Prepackaged Software
    Technology
    Telecommunications Equipment
    Telecommunications

    $ABT
    $BAH
    $DOCU
    $PRCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Porch Group Inc.

    SC 13G/A - Porch Group, Inc. (0001784535) (Subject)

    11/14/24 4:17:30 PM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Booz Allen Hamilton Holding Corporation

    SC 13G/A - Booz Allen Hamilton Holding Corp (0001443646) (Subject)

    11/14/24 1:22:34 PM ET
    $BAH
    Professional Services
    Consumer Discretionary

    SEC Form SC 13G/A filed by Porch Group Inc. (Amendment)

    SC 13G/A - Porch Group, Inc. (0001784535) (Subject)

    2/14/24 11:24:46 AM ET
    $PRCH
    Computer Software: Prepackaged Software
    Technology

    $ABT
    $BAH
    $DOCU
    $PRCH
    Financials

    Live finance-specific insights

    View All

    Docusign Announces Third Quarter Fiscal 2026 Financial Results

    SAN FRANCISCO, Dec. 4, 2025 /PRNewswire/ -- Docusign, Inc. (NASDAQ:DOCU) today announced results for its fiscal quarter ended October 31, 2025. Prepared remarks and the news release with the financial results will be accessible on Docusign's website at investor.docusign.com prior to its webcast. "Q3 was a strong quarter with growing customer investment into the IAM platform, where we now have more than 25,000 customers," said Allan Thygesen, CEO of Docusign. "Continued strong execution and improved efficiency led to one of the most robust top line growth and profitability quar

    12/4/25 4:05:00 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology

    Abbott to acquire Exact Sciences, a leader in large and fast-growing cancer screening and precision oncology diagnostics segments

    Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology diagnostics segmentsAcquisition will uniquely position Abbott to transform cancer care, advancing earlier detection and optimizing treatment and monitoring to help millions more people live healthier livesExact Sciences' product lines feature advanced cancer screening and diagnostic solutions, including the market-leading Cologuard® and Oncotype DX® tests, and cutting-edge liquid biopsy tests for multi-cancer early detection and molecular residual disease testingAcquisition will be immediately accretive to

    11/20/25 7:30:00 AM ET
    $ABT
    $EXAS
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical Specialities

    Docusign Announces Timing of Third Quarter Fiscal 2026 Earnings Conference Call

    SAN FRANCISCO, Nov. 13, 2025 /PRNewswire/ -- Docusign (NASDAQ:DOCU) today announced that its third quarter fiscal 2026 results will be released on Thursday, December 4, 2025, after the close of the market. The company will host a conference call at 2:00 p.m. Pacific Standard Time (5:00 p.m. Eastern Standard Time) to discuss its financial results. A live webcast of the event will be available on the Docusign Investor Relations website at investor.docusign.com. A live dial-in will be available domestically at 877-407-0784 or internationally at 201-689-8560. A replay will be available domestically at 844-512-2921 or internationally at 412-317-6671 until midnight (EST) December 18, 2025, using t

    11/13/25 6:03:00 PM ET
    $DOCU
    Computer Software: Prepackaged Software
    Technology